Toby Maher News Today

Daylesford Bulldogs' line-up hit by injuries as they prepare to face Gordon. Key player out, one in doubt. Can they keep their CHFL unbeaten streak?

STOCKHOLM, SWEDEN / ACCESSWIRE / May 20, 2024 / Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis reflected an increase in...

'These are among the two most exciting sets of results we've seen,' researcher says

Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid in IPFAdditional presentations include preclinical and translational data...

Vicore Announces Presentations at the 2024 American Thoracic Society ...

LYT-100 demonstrated ~50% improvement versus pirfenidone in key adverse events at a comparable exposure level, which may lead to better patient compliance and improved treatment outcomes in...

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th Annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

Gordon v Bungaree promises to be one of the big clashes of the season.

Patients treated with NAL ER demonstrated a 75.1% decrease in daytime cough frequency and a 76.1% decrease in 24-hour cough frequency compared with placebo.